Everett Harris & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.3M | Sell |
8,557
-265
| -3% | -$271K | 0.13% | 53 |
|
|
2026
Q1 | $8.11M | Sell |
8,822
-117
| -1% | -$119K | 0.1% | 57 |
|
|
2025
Q4 | $9.61M | Buy |
8,939
+50
| +0.6% | +$47.8K | 0.12% | 52 |
|
|
2025
Q3 | $6.78M | Sell |
8,889
-27
| -0.3% | -$20.1K | 0.08% | 67 |
|
|
2025
Q2 | $6.95M | Sell |
8,916
-59
| -0.7% | -$45.8K | 0.09% | 63 |
|
|
2025
Q1 | $7.41M | Sell |
8,975
-15
| -0.2% | -$12.5K | 0.1% | 59 |
|
|
2024
Q4 | $6.94M | Buy |
8,990
+11
| +0.1% | +$9.11K | 0.09% | 62 |
|
|
2024
Q3 | $7.95M | Sell |
8,979
-59
| -0.7% | -$53K | 0.1% | 59 |
|
|
2024
Q2 | $8.18M | Buy |
9,038
+100
| +1% | +$80K | 0.1% | 57 |
|
|
2024
Q1 | $6.95M | Buy |
8,938
+45
| +0.5% | +$32K | 0.09% | 63 |
|
|
2023
Q4 | $5.18M | Sell |
8,893
-31
| -0.3% | -$18.1K | 0.07% | 65 |
|
|
2023
Q3 | $4.79M | Buy |
8,924
+11
| +0.1% | +$5.67K | 0.07% | 66 |
|
|
2023
Q2 | $4.18M | Buy |
8,913
+233
| +3% | +$97.7K | 0.06% | 74 |
|
|
2023
Q1 | $2.98M | Buy |
8,680
+40
| +0.5% | +$13.5K | 0.05% | 78 |
|
|
2022
Q4 | $3.16M | Hold |
8,640
| – | – | 0.05% | 77 |
|
|
2022
Q3 | $2.79M | Sell |
8,640
-41
| -0.5% | -$13K | 0.05% | 80 |
|
|
2022
Q2 | $2.81M | Buy |
8,681
+358
| +4% | +$107K | 0.05% | 80 |
|
|
2022
Q1 | $2.38M | Hold |
8,323
| – | – | 0.03% | 96 |
|
|
2021
Q4 | $2.3M | Sell |
8,323
-11
| -0.1% | -$2.79K | 0.03% | 97 |
|
|
2021
Q3 | $1.93M | Buy |
8,334
+977
| +13% | +$241K | 0.03% | 100 |
|
|
2021
Q2 | $1.69M | Sell |
7,357
-327
| -4% | -$65.7K | 0.03% | 111 |
|
|
2021
Q1 | $1.44M | Sell |
7,684
-500
| -6% | -$97.8K | 0.02% | 115 |
|
|
2020
Q4 | $1.38M | Buy |
8,184
+467
| +6% | +$69.7K | 0.02% | 110 |
|
|
2020
Q3 | $1.14M | Sell |
7,717
-70
| -0.9% | -$10.8K | 0.02% | 118 |
|
|
2020
Q2 | $1.28M | Buy |
7,787
+241
| +3% | +$37K | 0.03% | 112 |
|
|
2020
Q1 | $1.05M | Buy |
+7,546
| New | +$1.04M | 0.03% | 118 |
|
|
2016
Q2 | – | Sell |
-5,490
| Closed | -$395K | – | 240 |
|
|
2016
Q1 | $395K | Hold |
5,490
| – | – | 0.01% | 187 |
|
|
2015
Q4 | $463K | Hold |
5,490
| – | – | 0.02% | 174 |
|
|
2015
Q3 | $459K | Hold |
5,490
| – | – | 0.02% | 177 |
|
|
2015
Q2 | $458K | Buy |
5,490
+290
| +6% | +$22.1K | 0.02% | 178 |
|
|
2015
Q1 | $378K | Hold |
5,200
| – | – | 0.01% | 182 |
|
|
2014
Q4 | $359K | Buy |
5,200
+200
| +4% | +$13.5K | 0.01% | 180 |
|
|
2014
Q3 | $324K | Hold |
5,000
| – | – | 0.01% | 189 |
|
|
2014
Q2 | $311K | Hold |
5,000
| – | – | 0.01% | 191 |
|
|
2014
Q1 | $294K | Hold |
5,000
| – | – | 0.01% | 196 |
|
|
2013
Q4 | $255K | Hold |
5,000
| – | – | 0.01% | 196 |
|
|
2013
Q3 | $252K | Hold |
5,000
| – | – | 0.01% | 184 |
|
|
2013
Q2 | $246K | Buy |
+5,000
| New | +$272K | 0.01% | 190 |
|
Other funds holding LLY
Everett Harris & Co's LLY Position: Q2 2026 in Review
Everett Harris & Co reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $271K and leaving 8,557 shares worth $10.3M. The position accounts for 0.13% of the portfolio, ranked #53.
Everett Harris & Co first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Everett Harris & Co held 8,557 shares of Eli Lilly worth $10.3M as of Q2 2026.
- Everett Harris & Co sold 265 Eli Lilly shares in Q2 2026, an estimated $271K.
- Eli Lilly made up 0.13% of Everett Harris & Co's portfolio in Q2 2026, its #53 holding.
- Everett Harris & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.